Modulatory/JJ
effects/NNS
of/IN
glucocorticoids/NNS
and/CC
catecholamines/NNS
on/IN
human/JJ
interleukin-12/NN
and/CC
interleukin-10/NN
production/NN
:/:
clinical/JJ
implications/NNS
./.

Interleukin-12/NN
(/(
IL-12/NN
)/)
is/VBZ
a/DT
key/JJ
inducer/NN
of/IN
differentiation/NN
of/IN
uncommitted/JJ
T/NN
helper/NN
(/(
TH/NN
)/)
cells/NNS
toward/IN
the/DT
TH1/NN
phenotype/NN
,/,
which/WDT
regulates/VBZ
cellular/JJ
immunity/NN
,/,
whereas/IN
IL-10/NN
inhibits/VBZ
TH1/NN
functions/NNS
and/CC
potentiates/VBZ
TH2-regulated/JJ
responses/NNS
(/(
i.e./FW
,/,
humoral/JJ
immunity/NN
)/)
./.
=====
To/TO
examine/VB
the/DT
potential/JJ
effects/NNS
of/IN
stress/NN
on/IN
TH1/TH2/NN
balance/NN
,/,
we/PRP
studied/VBD
the/DT
ability/NN
of/IN
three/CD
prototype/NN
stress/NN
hormones/NNS
-/:
dexamethasone/NN
(/(
a/DT
synthetic/JJ
glucocorticoid/NN
)/)
and/CC
the/DT
catecholamines/NNS
norepinephrine/NN
and/CC
epinephrine/NN
-/:
to/TO
alter/VB
the/DT
production/NN
of/IN
IL-12/NN
(/(
p70/NN
)/)
and/CC
IL-10/NN
induced/VBN
by/IN
bacterial/JJ
lipopolysaccharide/NN
(/(
LPS/NN
)/)
in/IN
human/JJ
whole/JJ
blood/NN
./.
=====
Dexamethasone/NN
inhibited/VBD
LPS-induced/JJ
bioactive/JJ
IL-12/NN
production/NN
in/IN
a/DT
dose-dependent/JJ
fashion/NN
and/CC
at/IN
physiologically/RB
relevant/JJ
concentrations/NNS
;/:
it/PRP
had/VBD
no/DT
effect/NN
on/IN
IL-10/NN
secretion/NN
./.
=====
The/DT
glucocorticoid-induced/JJ
reduction/NN
of/IN
IL-12/NN
production/NN
was/VBD
antagonized/VBN
by/IN
RU/NN
486/CD
,/,
a/DT
glucocorticoid-receptor/JJ
antagonist/NN
,/,
suggesting/VBG
that/IN
it/PRP
was/VBD
mediated/VBN
by/IN
the/DT
glucocorticoid/NN
receptor/NN
./.
=====
Norepinephrine/NN
and/CC
epinephrine/NN
also/RB
suppressed/VBD
IL-12/NN
production/NN
in/IN
a/DT
dose-dependent/JJ
fashion/NN
and/CC
at/IN
physiological/JJ
concentrations/NNS
;/:
both/DT
catecholamines/NNS
,/,
however/RB
,/,
dose-dependently/RB
increased/VBD
the/DT
production/NN
of/IN
IL-10/NN
./.
=====
The/DT
effects/NNS
of/IN
either/DT
catecholamine/NN
on/IN
IL-12/NN
or/CC
IL-10/NN
secretion/NN
were/VBD
blocked/VBN
completely/RB
by/IN
propranolol/NN
,/,
a/DT
beta-adrenoreceptor/JJ
antagonist/NN
,/,
indicating/VBG
that/IN
they/PRP
were/VBD
mediated/VBN
by/IN
the/DT
beta-adrenergic/JJ
receptor/NN
./.
=====
These/DT
findings/NNS
suggest/VBP
that/IN
the/DT
central/JJ
nervous/JJ
system/NN
may/MD
regulate/VB
IL-12/NN
and/CC
IL-10/NN
secretion/NN
and/CC
,/,
hence/RB
,/,
TH1/TH2/NN
balance/NN
via/IN
the/DT
peripheral/JJ
end-effectors/NNS
of/IN
the/DT
stress/NN
system/NN
./.
=====
Thus/RB
,/,
stress/NN
may/MD
cause/VB
a/DT
selective/JJ
suppression/NN
of/IN
TH1/NN
functions/NNS
and/CC
a/DT
shift/NN
toward/IN
a/DT
TH2/NN
cytokine/NN
pattern/NN
rather/RB
than/IN
generalized/JJ
TH/NN
suppression/NN
./.
=====
The/DT
TH1-to-TH2/JJ
shift/NN
may/MD
be/VB
responsible/JJ
for/IN
the/DT
stress-induced/JJ
susceptibility/NN
of/IN
the/DT
organism/NN
to/TO
certain/JJ
infections/NNS
./.
=====
Through/IN
the/DT
same/JJ
or/CC
a/DT
reciprocal/JJ
mechanism/NN
,/,
states/NNS
associated/VBN
with/IN
chronic/JJ
hyperactivity/NN
or/CC
hypoactivity/NN
of/IN
the/DT
stress/NN
system/NN
might/MD
influence/VB
the/DT
susceptibility/NN
of/IN
an/DT
individual/NN
to/TO
certain/JJ
autoimmune/JJ
,/,
allergic/JJ
,/,
infectious/JJ
,/,
or/CC
neoplastic/JJ
diseases/NNS
./.